Related Experiment Video

Updated: Oct 8, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus

S E Truesdell1, G E Zurenko, A L Laborde

  • 1Research Laboratories, Upjohn Company, Kalamazoo, MI 49001.

The Journal of Antimicrobial Chemotherapy
|April 1, 1989
PubMed

Insights

Cefmetazole shows strong binding to key penicillin-binding proteins (PBPs) in methicillin-resistant Staphylococcus aureus (MRSA), including PBP2a. This interaction may explain the lower minimum inhibitory concentrations (MICs) observed for cefmetazole against MRSA.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its resistance to common antibiotics.
  • Penicillin-binding proteins (PBPs) are crucial targets for beta-lactam antibiotics, including cephalosporins.

Purpose of the Study:

  • To compare the binding affinities of cefmetazole, cefazolin, cefotetan, and cefoxitin to essential PBPs of MRSA.
  • To investigate the relationship between PBP binding and the antimicrobial activity of cefmetazole against MRSA.

Main Methods:

  • In vitro assessment of antibiotic binding affinities to purified MRSA PBPs.
  • Comparison of binding data with reported minimum inhibitory concentrations (MICs).

Main Results:

  • Cefmetazole demonstrated comparable or higher affinity for PBP1, PBP2, and PBP3 compared to cefotetan and cefoxitin.
  • Cefmetazole exhibited a notably greater affinity for PBP2' (PBP2a) than cefazolin, cefotetan, and cefoxitin.
  • Cefazolin showed the highest affinity for PBP1, PBP2, and PBP3.

Conclusions:

  • The enhanced affinity of cefmetazole for PBP2' may contribute to its observed lower MICs against MRSA.
  • Understanding PBP binding profiles is critical for developing effective anti-MRSA therapies.

More Related Videos

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

In Vitro Evaluation of the Potentiating Effects of Plant-Derived Molecules on Conventional Biocides09:21

In Vitro Evaluation of the Potentiating Effects of Plant-Derived Molecules on Conventional Biocides

Published on: May 8, 2026

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...